Search Results - "Hutka, Margaret"

41 - Clinical and Molecular profiling of KRAS G12C lung adenocarcinomas by Bulusu, Venkata, Jessop, Susan, Paul, Sherin, Chapman, Timothy, Ben-Gashir, Mohamed, Geetha, Anil, Punnen, Geethu, Aslam, Shahzeena, Hutka, Margaret

Get full text

69 - Immune-related thyroid dysfunction in lung cancer patients treated with PD-1/PD-L1 checkpoint inhibitors by Bulusu, Venkata, Jessop, Susan, Paul, Sherin, Chapman, Timothy, Aslam, Shahzeena, Jeffs, Yvonne, Punnen, Geethu, Geetha, Anil, Hutka, Margaret

Get full text

Immune-related thyroid dysfunction in lung cancer patients treated with PD-1/PD-L1 checkpoint inhibitors by Bulusu, Venkata, Jessop, Susan, Paul, Sherin, Chapman, Timothy, Aslam, Shahzeena, Jeffs, Yvonne, Punnen, Geethu, Geetha, Anil, Hutka, Margaret

Get full text

Clinical and Molecular profiling of KRAS G12C lung adenocarcinomas by Bulusu, Venkata, Jessop, Susan, Paul, Sherin, Chapman, Timothy, Ben-Gashir, Mohamed, Geetha, Anil, Punnen, Geethu, Aslam, Shahzeena, Hutka, Margaret

Get full text

Rucaparib in patients with BAP1-deficient or BRCA1-deficient mesothelioma (MiST1): an open-label, single-arm, phase 2a clinical trial by Fennell, Dean A, King, Amy, Mohammed, Seid, Branson, Amy, Brookes, Cassandra, Darlison, Liz, Dawson, Alan G, Gaba, Aarti, Hutka, Margaret, Morgan, Bruno, Nicholson, Adrian, Richards, Cathy, Wells-Jordan, Peter, Murphy, Gavin James, Thomas, Anne, Fennell, Dean Anthony, King, Amy, Mohammed, Seid, Branson, Amy, Brooks, Cassandra, Darlison, Liz, Dawson, Alan George, Gaba, Aarti, Hutka, Margaret, Morgan, Bruno, Nicholson, Adrian, Richards, Cathy, Wells-Jordan, Peter, Murphy, Gavin James, Thomas, Anne, Anthony, Sarah, Bhundia, Vina, Cowley, Caroline, Poile, Charlotte, Scotland, Molly

“…Malignant mesothelioma remains an incurable cancer, with no effective treatments in the setting of relapsed disease. Homologous recombination deficiency…”
Get full text

Abemaciclib in patients with p16ink4A-deficient mesothelioma (MiST2): a single-arm, open-label, phase 2 trial by Fennell, Dean A, King, Amy, Mohammed, Seid, Greystoke, Alastair, Anthony, Sarah, Poile, Charlotte, Nusrat, Nada, Scotland, Molly, Bhundia, Vina, Branson, Amy, Brookes, Cassandra, Darlison, Liz, Dawson, Alan G, Gaba, Aarti, Hutka, Margaret, Morgan, Bruno, Bajaj, Amrita, Richards, Cathy, Wells-Jordan, Peter, Thomas, Anne, Fennell, Dean A., King, Amy, Greystoke, Alastair, Anthony, Sarah, Moody, Sam, Poille, Charlotte, Nusrat, Nada, Scotland, Molly, Bhundia, Vina, Branson, Amy, Brookes, Cassandra, Darlison, Liz, Dawson, Alan G., Gaba, Aarti, Hutka, Margaret, Morgan, Bruno, Bajaj, Amrita, Richards, Cathy, Wells-Jordan, Peter, Nicolson, Adrian, Underwood, Judith, Sodha-Ramdeen, Azmina, Cowley, Caroline, Barber, Shaun, Thomas, Anne

“…Genetically stratified therapy for malignant mesothelioma is unavailable. Mesotheliomas frequently harbour loss of the chromosome 9p21.3 locus (CDKN2A–MTAP),…”
Get full text

4 Clinical and molecular characteristics of BRAF mutant Lung Adenocarcinomas by Bulusu, Ramesh, Bulusu, Ramesh, Yang, Huiqi, Patterson, Daniel, Thippu Jayaprakash, Kamalram, McGeogh, Adam, Hutka, Margaret, Hollingdale, Abigail, Treece, Sarah, Thompson, Nicola, Earwaker, Philip, Lynskey, Diedre, Aslam, Shahzeena, Shiarli, Anna Marie

Get full text

A phase II trial of abemaciclib in patients with p16ink4a negative, relapsed mesothelioma by Fennell, Dean Anthony, King, Amy, Mohammed, Seid, Branson, Amy, Greystoke, Alastair, Moody, Sam, Hutka, Margaret, Dawson, Alan G., Darlison, Liz, Scotland, Molly, Bhundia, Vina, Bajaj, Amrita, Morgan, Bruno, Nicholson, Adrian, Brookes, Cassandra, Gaba, Aarti, Wells-Jordan, Peter, Richards, Catherine Jane, Thomas, Anne

“…Abstract only 8558 Background: Genetically stratified therapy for malignant mesothelioma (MM) is lacking. MMs frequently harbour loss of chromosome 9p21.3…”
Get full text

E10. Current multidisciplinary management in breast cancer by Hutka, Margaret, Sousa, Berta, Ades, Felipe, van de Vorst, Joost, Bonomo, Pierluigi, De Mattos-Arruda, Leticia

Get full text

Implications of BRCA1 and BRCA2 mutations for the efficacy of paclitaxel monotherapy in advanced ovarian cancer by Tan, David S.P, Yap, Timothy A, Hutka, Margaret, Roxburgh, Patricia, Ang, Jooern, Banerjee, Susana, Grzybowska, Ewa, Gourley, Charlie, Gore, Martin E, Kaye, Stan B

“…Abstract Introduction Preclinical data suggest that BRCA1 and BRCA2 ( BRCA1/2 )-mutated ovarian cancers (BMOC) are exquisitely sensitive to platinum-salts, but…”
Get full text

Rapid access clinic for unexplained lymphadenopathy and suspected malignancy: prospective analysis of 1000 patients by Kühnl, Andrea, Cunningham, David, Hutka, Margaret, Peckitt, Clare, Rozati, Hamoun, Morano, Federica, Chong, Irene, Gillbanks, Angela, Wotherspoon, Andrew, Harris, Michelle, Murray, Tracey, Chau, Ian

“…In patients presenting with peripheral lymphadenopathy, it is critical to effectively identify those with underlying cancer who require urgent specialist care…”
Get full text